Loading...
XSHE
300030
Market cap272mUSD
Jul 10, Last price  
6.17CNY
1D
3.18%
1Q
-19.97%
Jan 2017
-54.83%
IPO
66.36%
Name

GZ IMPROVE MEDICAL INSTRUMENTS CO.

Chart & Performance

D1W1MN
XSHE:300030 chart
P/E
131.29
P/S
3.92
EPS
0.05
Div Yield, %
Shrs. gr., 5y
-1.22%
Rev. gr., 5y
-9.47%
Revenues
486m
-16.35%
103,447,988140,793,354165,866,083249,639,335304,084,984396,737,492461,792,179545,348,931517,103,042549,652,841549,963,261575,061,342919,225,503799,833,986799,833,986710,768,471710,768,471644,621,152581,328,009486,260,010
Net income
15m
P
20,462,03626,905,04029,020,72135,674,85537,472,26346,119,86753,057,21239,835,21030,477,44811,158,467-136,801,36126,024,211162,515,17218,568,52918,568,5380-198,300,068-63,203,833-117,903,78514,530,384
CFO
110m
+34.29%
6,570,9942,651,19824,764,33333,034,20928,855,39838,862,92036,062,20444,381,2530023,185,032142,192,98056,036,17749,162,409141,274,052171,738,97242,478,05879,904,93281,835,065109,895,743
Dividend
Jul 06, 20220.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Improve Medical Instruments Co., Ltd. operates as an international supplier, delivering advanced technologies, medical products, and critical services to clinical laboratories and for patient care, spanning both the Chinese market and global regions. A significant portion of its product portfolio comprises leading brands such as IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transport systems, IMPRONURSE infusion and syringe pumps, and LONGX urine analysis platforms, alongside an assortment of in-vitro diagnostic reagents. Furthermore, the company's comprehensive offerings extend to a wide range of ancillary equipment and disposables, including blood collection needles, pulsewave blood pressure monitors, thrombosis viscoelastic analysis systems, feces analysis systems, automated blood and urine collection tube preparation systems, graphical user interface (GUI) devices, intelligent sorting units, multi-functional blood collection workstations, smart queue management systems, automatic tube packing systems, and consumable labels. Originally incorporated in 1996 as Guangzhou Improve Medical Instruments Co., Ltd., the enterprise maintains its headquarters in Guangzhou, China.
IPO date
Dec 25, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT